M. Ravinder

993 total citations
38 papers, 827 citations indexed

About

M. Ravinder is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, M. Ravinder has authored 38 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 12 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in M. Ravinder's work include Synthesis and Biological Evaluation (12 papers), Synthesis and Characterization of Heterocyclic Compounds (10 papers) and Synthesis of heterocyclic compounds (9 papers). M. Ravinder is often cited by papers focused on Synthesis and Biological Evaluation (12 papers), Synthesis and Characterization of Heterocyclic Compounds (10 papers) and Synthesis of heterocyclic compounds (9 papers). M. Ravinder collaborates with scholars based in India, Taiwan and Portugal. M. Ravinder's co-authors include V. Jayathirtha Rao, Chung‐Yi Wu, Sirassu Narsimha, P. Narender, B. Gangadasu, Satheesh Kumar Nukala, Boddu Ananda Rao, U. S. N. Murthy, U. Srinivas and N. Vasudeva Reddy and has published in prestigious journals such as The Journal of Organic Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

M. Ravinder

36 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ravinder India 16 678 296 47 32 29 38 827
Maxime Robin France 15 337 0.5× 252 0.9× 61 1.3× 36 1.1× 24 0.8× 36 669
Seiya Kitamura United States 15 502 0.7× 525 1.8× 34 0.7× 16 0.5× 48 1.7× 31 904
Sahar Kandil United Kingdom 12 280 0.4× 188 0.6× 26 0.6× 17 0.5× 27 0.9× 19 525
Steven J. Stanway United Kingdom 14 263 0.4× 162 0.5× 65 1.4× 24 0.8× 47 1.6× 24 526
Muriel Duflos France 15 501 0.7× 202 0.7× 96 2.0× 14 0.4× 44 1.5× 48 732
Syed Khalid Yousuf India 21 793 1.2× 460 1.6× 87 1.9× 18 0.6× 68 2.3× 47 1.1k
Konrad Kubiński Poland 15 302 0.4× 329 1.1× 69 1.5× 16 0.5× 33 1.1× 45 748
Ya-Qiu Long United States 19 388 0.6× 407 1.4× 33 0.7× 8 0.3× 34 1.2× 23 818
Daniel K. Baeschlin United Kingdom 12 479 0.7× 397 1.3× 77 1.6× 9 0.3× 49 1.7× 17 649
Steven L. Roach United States 10 253 0.4× 269 0.9× 61 1.3× 12 0.4× 56 1.9× 17 573

Countries citing papers authored by M. Ravinder

Since Specialization
Citations

This map shows the geographic impact of M. Ravinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ravinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ravinder more than expected).

Fields of papers citing papers by M. Ravinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ravinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ravinder. The network helps show where M. Ravinder may publish in the future.

Co-authorship network of co-authors of M. Ravinder

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ravinder. A scholar is included among the top collaborators of M. Ravinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ravinder. M. Ravinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravinder, M., Yang‐Yu Cheng, Mei‐Hua Hsu, et al.. (2024). Chemical Synthesis of Truncated Capsular Oligosaccharide of Serotypes 6C and 6D of Streptococcus pneumoniae with Their Immunological Studies. ACS Infectious Diseases. 10(6). 2161–2171.
2.
Ravinder, M., et al.. (2021). One-Pot Regioselective Synthesis of 7-Bromo-2H-Benzo[b][1,4]Oxazin-3(4H)-One Linked Isoxazole Hybrids as Anti-Cancer Agents and Their Molecular Docking Studies. Russian Journal of Bioorganic Chemistry. 47(6). 1269–1275. 3 indexed citations
3.
Banala, Srinivas, et al.. (2021). Synthesis of Quinoxlines Containing 1,2,3-Triazoles and Their Anti-Bacterial and Anti-Cancer Activity. Russian Journal of Bioorganic Chemistry. 47(4). 882–888. 4 indexed citations
4.
Ravinder, M., Chien‐Tai Ren, Yu‐Wei Lin, et al.. (2020). Synthesis of Asymmetric N-Glycans as Common Core Substrates for Structural Diversification through Selective Enzymatic Glycosylation. ACS Chemical Biology. 15(9). 2382–2394. 14 indexed citations
5.
Ravinder, M., et al.. (2020). Synthetic carbohydrate-based vaccines: challenges and opportunities. Journal of Biomedical Science. 27(1). 9–9. 113 indexed citations
6.
Ravinder, M., et al.. (2020). One-pot synthesis of sulfonyl-1 H -1,2,3-triazolyl-thiomorpholine 1,1-dioxide derivatives and evaluation of their biological activity. Phosphorus, sulfur, and silicon and the related elements. 196(5). 455–460. 17 indexed citations
7.
Ravinder, M., et al.. (2019). Microwave-assisted one pot synthesis of fused [1,2,3]triazolo-pyrano[3,2-h]quinolines and their biological evaluation. Asian Journal of Pharmacy and Pharmacology. 5(6). 1202–1210. 7 indexed citations
8.
Ravinder, M., et al.. (2017). Design, synthesis, and biological evaluation of 4-H pyran derivatives as antimicrobial and anticancer agents. Medicinal Chemistry Research. 26(11). 2832–2844. 33 indexed citations
9.
Srinivas, B., et al.. (2016). Synthesis and anti-microbial activity of novel series of N-(substituted phenyl-1H-tetrazol-1-yl)-7-substituted tetrazolo [1,5-a]quinoxalin-4yl-aminederivatives. Der pharma chemica. 8(1). 84–93. 1 indexed citations
10.
Ravinder, M., Pankaj K. Bagul, Chandrakant Bagul, et al.. (2013). Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs). European Journal of Medicinal Chemistry. 71. 53–66. 60 indexed citations
11.
Ravinder, M., et al.. (2013). Synthesis, antitubercular and anticancer activity of new Baylis–Hillman adduct-derived N-cinnamyl-substituted isatin derivatives. Medicinal Chemistry Research. 23(4). 1934–1940. 29 indexed citations
12.
Ravinder, M., et al.. (2012). Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): A target for heart failure and platelet aggregation. Bioorganic & Medicinal Chemistry Letters. 22(18). 6010–6015. 50 indexed citations
15.
Gangadasu, B., M. Ravinder, B. China Raju, et al.. (2009). Synthesis, photochemical E (trans)→Z (cis) isomerization and antimicrobial activity of 2-chloro-5-methylpyridine-3-olefin derivatives. European Journal of Medicinal Chemistry. 44(11). 4661–4667. 15 indexed citations
16.
Narender, P., et al.. (2009). Synthesis of Substituted 1,8‐Naphthyridine‐3‐carboxylates from Baylis–Hillman Adducts of Substituted 2‐Chloronicotinaldehydes. Helvetica Chimica Acta. 92(5). 959–966. 20 indexed citations
18.
Ravinder, M., et al.. (2009). Photochemical dehydrogenation of 3,4-dihydro-2-pyridones. Photochemical & Photobiological Sciences. 8(4). 513–515. 7 indexed citations
19.
Narender, P., U. Srinivas, M. Ravinder, et al.. (2006). Synthesis of multisubstituted quinolines from Baylis–Hillman adducts obtained from substituted 2-chloronicotinaldehydes and their antimicrobial activity. Bioorganic & Medicinal Chemistry. 14(13). 4600–4609. 123 indexed citations
20.
Gangadasu, B., P. Narender, M. Ravinder, et al.. (2006). Facile and selective synthesis of chloronicotinaldehydes by the Vilsmeier reaction. Tetrahedron. 62(35). 8398–8403. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026